- Home
- CODA vs XBIT Comparison
CODA vs XBIT Comparison
Compare CODA & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- XBIT
- Stock Information
- Founded
- CODA 1994
- XBIT 2005
- Country
- CODA United States
- XBIT United States
- Employees
- CODA N/A
- XBIT N/A
- Industry
- CODA Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- CODA Industrials
- XBIT Health Care
- Exchange
- CODA Nasdaq
- XBIT Nasdaq
- Market Cap
- CODA 88.8M
- XBIT 86.3M
- IPO Year
- CODA N/A
- XBIT 2015
- Fundamental
- Price
- CODA $8.08
- XBIT $2.73
- Analyst Decision
- CODA Strong Buy
- XBIT
- Analyst Count
- CODA 1
- XBIT 0
- Target Price
- CODA $11.00
- XBIT N/A
- AVG Volume (30 Days)
- CODA 80.8K
- XBIT 52.9K
- Earning Date
- CODA 09-15-2025
- XBIT 11-12-2025
- Dividend Yield
- CODA N/A
- XBIT N/A
- EPS Growth
- CODA 15.09
- XBIT N/A
- EPS
- CODA 0.30
- XBIT N/A
- Revenue
- CODA $24,347,217.00
- XBIT N/A
- Revenue This Year
- CODA $30.82
- XBIT N/A
- Revenue Next Year
- CODA $20.84
- XBIT N/A
- P/E Ratio
- CODA $26.33
- XBIT N/A
- Revenue Growth
- CODA 29.34
- XBIT N/A
- 52 Week Low
- CODA $5.76
- XBIT $2.50
- 52 Week High
- CODA $9.89
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- CODA 52.95
- XBIT 36.79
- Support Level
- CODA $7.85
- XBIT $2.69
- Resistance Level
- CODA $8.80
- XBIT $3.61
- Average True Range (ATR)
- CODA 0.38
- XBIT 0.15
- MACD
- CODA 0.01
- XBIT -0.04
- Stochastic Oscillator
- CODA 39.50
- XBIT 4.65
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.